Stocks & Equities

Todd Market Forecast for 3 PM PST Monday October 5, 2015

DOW                                                    +300 on 2400 net advances
 
NASDAQ COMP                                     + 73 on 1450 net advances
 
SHORT TERM TREND                            Bullish
 
INTERMEDIATE TERM TREND               Bullish
 
STOCKS :  There’s an old market saying. The stock market won’t let you in on your own terms. I wanted to buy this, but I didn’t want to buy a gap opening. More on this in the trading section below.
       Now to the markets. The reason given for the big move today was that  the weak employment numbers last Friday would keep the Fed from raising rates. 
       Just to see how silly that reasoning is, consider the following: Back on September 18, the Dow lost 290 points on the theory that the Fed failed to raise rates because of a weak economy. 
       We have a different take. We’ve been selling for weeks and the sellers are exhausted. They’re sold out. When you’ve sold all your stock, the only way to get it to decline further is to cheer. 
      The market inhales and exhales. Today it is inhaling. 
 
GOLD:  Gold barely moved. We’ll stay bullish for now.  
 
CHART:  On the initial downleg ending in late August, there were almost 1500 more weekly lows than weekly highs. On the retest, there were around 750. This tells us that the market is firming.
 
978
BOTTOM LINE:  (Trading)
Our intermediate term system is on a buy as of August 26.
System 7   We missed the price we were looking for. Stay in cash. We’re very overbought. We have to be patient.         
System 8   We are in cash. Stay there.                    
GOLD  We are in cash. Stay there.     
 
News and fundamentals:  The ISM non manufacturing data was 56.9, less than the expected 8.0. On Tuesday we get the trade deficit.
 
Interesting Stuff : Ben Bernanke was on CNBC today, patting himself on the back. If he’s so wonderful, why hasn’t the economy responded better to his QE ad infinitim?
 
TORONTO EXCHAN GE:   Toronto gained 212.                
S&P/TSX VENTURE COMP: The TSX was 4.          
BONDS:  Bonds had a solid down session.                                                                                              
THE REST:  The dollar bounced a bit. Silver surged and crude oil was higher.                                                 
 
Bonds — Bullish since September 4.                           
 
U.S. dollar –Bullish since September 21.                            
 
Euro — Bearish since August 26.
 
Gold —-Bullish since September 24.                              
 
Silver—- Bullish since October 2.                           
 
Crude oil —- Bullish since September 16.                               
 
Toronto Stock Exchange—- Bullish since August 27.    
 
S&P\ TSX Venture Fund — Bullish since August 27.    
 
We are on a long term buy signal for the markets of the U.S., Canada, Britain, Germany and France.  
Mon. Tue. Wed. Thu. Fri. Mon. Evaluation
Monetary conditions 0 0 0 0 0 0 0
5 day RSI S&P 500 15 18 47 50 65 76
5 day RSI NASDAQ 10 9 40 41 58 68  0
McCl-
lAN OSC.
-136 -130 -23 -17 +65 +185
 
Composite Gauge 17 12 5 7 5 5
Comp. Gauge, 5 day m.a. 14.4 13.9 12.2 10.4 9.2 6.8
CBOE Put Call Ratio 1.43 1.36 .84 .95 1.09 1.00
+
 
VIX 27.63 26.83 24.50 22.55 20.87 19.54 0
VIX % change +17 -3 -9 -8 -7 -7
VIX % change 5 day m.a. +6.8 +4.0 +2.4 -0.6 -2.0 -6.8
Adv – Dec 3 day m.a. -1136 -1045 -480 +336 +979 +1257  –
Supply Demand 5 day m.a. .39 .40 .52 .53 .67 .85
Trading Index (TRIN) 1.43 .64 .42 .83 .54 .48
 0
 
S&P 500
 
1882 1884 1920 1924 1951 1987 Plurality -7
 INDICATOR PARAMETERS
     Monetary conditions (+2 means the Fed is actively dropping rates; +1 means a bias toward easing. 0 means neutral, -1 means a bias toward tightening, -2 means actively raising rates). RSI (30 or below is oversold, 80 or above is overbought). McClellan Oscillator ( minus 100 is oversold. Plus 100 is overbought). Composite Gauge (5 or below is negative, 13 or above is positive). Composite Gauge five day m.a. (8.0 or below is overbought. 13.0 or above is oversold). CBOE Put Call Ratio ( .80 or below is a negative. 1.00 or above is a positive). Volatility Index, VIX (low teens bearish, high twenties bullish), VIX % single day change. + 5 or greater bullish. -5 or less, bearish. VIX % change 5 day m.a. +3.0 or above bullish, -3.0 or below, bearish. Advances minus declines three day m.a.( +500 is bearish. – 500 is bullish). Supply Demand 5 day m.a. (.45 or below is a positive. .80 or above is a negative). Trading Index (TRIN) 1.40 or above bullish. No level for bearish.
      No guarantees are made. Traders can and do lose money. The publisher may take positions in recommended securities.

Stock Trading Alert: Positive Expectations Following Last Week’s Rebound

Stock Trading Alert originally published on October 5, 2015, 6:46 AM:

Briefly: In our opinion, speculative long positions are favored (with stop-loss at 1,900, and profit target at 2,020, S&P 500 index)

Our intraday outlook is bullish, and our short-term outlook is bullish:

Intraday outlook (next 24 hours): bullish
Short-term outlook (next 1-2 weeks): bullish
Medium-term outlook (next 1-3 months): bearish
Long-term outlook (next year): bullish

The U.S. stock market indexes gained between 1.2% and 1.8% on Friday, as investors reacted to economic data releases. Our Friday’s bullish intraday outlook has proved accurate. The S&P 500 index broke above its recent short-term consolidation. The nearest important resistance level is at 1,950, and the next level of resistance is at 2,000-2,020 marked by local high. On the other hand, support level is at 1,870-1,900:

39138 a largeLarger Image

Expectations before the opening of today’s trading session are positive, with index futures currently up 0.5-0.7%. The main European

stock market indexes have gained 2.1-3.2% so far. Investors will now wait for the ISM Services number release at 10:00 a.m. The S&P 500 futures contract (CFD) is within an intraday uptrend, as it currently trades slightly above the level of 1,950. The nearest important level of support is at around 1,920, as the 15-minute chart shows:

 

39138 b large
Larger Image

The technology Nasdaq 100 futures contract (CFD) follows a similar path, as it extends its last week’s move up. The nearest important level of resistance is at 4,300, and support level remains at 4,250, among others, as we can see on the 15-minute chart:

39138 c largeLarger Image

Concluding, the broad stock market extended its short-term uptrend on Friday, following volatile trading session. There have been no confirmed positive signals so far. However, we continue to maintain our already profitable speculative long position (1,881.90, S&P 500 index), as we expect an upward correction or downtrend reversal. We decided to move our stop-loss level to 1,900 (S&P 500 index), to protect our gains. Potential profit target remains at 2,020. You can trade S&P 500 index using futures contracts (S&P 500 futures contract – SP, E-mini S&P 500 futures contract – ES) or an ETF like the SPDR S&P 500 ETF – SPY. It is always important to set some exit price level in case some events cause the price to move in the unlikely direction. Having safety measures in place helps limit potential losses while letting the gains grow.

Thank you.

Market Buzz – Canadian Pharma Stocks Big and Small Face Wild Week

page1 img1It was a wild ride for Toronto’s main index this past week as what was Canada’s largest company by market cap, Valeant Pharmaceuticals Intl Inc. (VRX:TSX), woke up Monday to a significant storm.

Democrats on the U.S. House of Representatives committee on oversight and government reform sent a letter to the committee’s Republican chairman seeking a subpoena that would force Valeant, to turn over documents tied to the U.S. price hikes of two heart drugs. 

At one stage Valeant’s shares traded down 16% before recovering a portion of the losses. The pharma sector itself was off over 10% on Monday alone. Well respected fellow Canadian Pharma stock Concordia Healthcare Corp (CXR:TSX) which, like Valeant, has an aggressive acquisition strategy, whereby it manages and acquires legacy pharmaceutical products and acquires and develops orphan drugs, fell more than 25% on Monday.

At issue for both was the practice of hiking drug prices after acquisition. Reports state that Valeant’s heart drugs, Nitropress and Isuprel, saw a 212% and 525% price increase after Valeant acquired them. 

Politicians have chimed in on the issue as Hillary Clinton’s tweet this week received significant attention: “Price gouging like this in the specialty drug market is outrageous.”

Clearly, sky-rocketing drug prices is an area of focus for a number of Democratic presidential-hopefuls and raises a spectre of uncertainty for companies selling into the U.S. market at present.

Concordia is also facing backlash from investors who subscribed to the company’s recent US$520 million financing which was priced in the CDN$88.80 range. The financing closed last week and the company’s shares have already dropped 35%. While Concordia is up over 23% year-to-date and have been a tremendous success story over the past several years, these are not the best time to be a new owner of the company’s shares. 

There have been rumblings that investors in the recent offering may try and use the so-called material out clause to get them out of their purchases. This would be a very rare occurrence, but those feeling burned are wondering aloud what they can do or if anything can be done. 

We would suggest that this is the risk of subscribing to a financing which prices in a current price-to-earnings multiple in the range of 100. The valuations were extremely rich. While the promise of growth is enticing, we have now witnessed firsthand the type of violent drop that can occur in a stock that is “priced to perfection” when the company hits a bump in the road. It is not pretty. 

The silver lining here is that asset prices have come down and we are starting to see value once again from a market that offered little by early to mid 2015. While issues may be on the horizon for U.S. exposed pharma stocks, those exposed to other regions including Europe (such as our top pick in the sector), could be trading at bargain levels. 


KeyStone’s Latest Reports Section

10/1/2015
CASH RICH UNIQUE TECH DRIVEN MICRO-CAP POSTS RECORD Q2 2015, SOLID BUT DECLINING BACKLOG, SHARES SURGE 50% – RATINGS MAINTAINED

9/28/2015
P&C INSURANCE OPERATOR POSTS BOUNCE BACK Q2 2015 RESULTS, MODERATE NEAR-TERM GROWTH, SOLID LONG-TERM – MAINTAIN RATING

9/24/2015
STAPLE AUTO REPAIR COMPANY ANNOUNCES RECORD Q2 2015 RESULTS, REVENUE & ADJUSTED EBITDA GROWTH ACCELERATES – STOCK UP OVER 2,500% – MAINTAIN RATING

9/10/2015
CASH RICH SOFTWARE AND SOLUTIONS SMALL-CAP NAMES EUROPEAN CABLE CONTRACT, SETS DEPLOYMENT TIMEFRAME, AND PARTNER REPORTS SIGNIFICANT SUBSCRIBER INCREASE – MAINTAIN BUY

9/10/2015
CASH RICH COMMUNICATIONS SOFTWARE & HARDWARE PROVIDES WEAKER Q3 GUIDANCE – RATING LOWERED


Disclaimer | ©2015 KeyStone Financial Publishing Corp.

Outperforming The Market – CWS Market Review

“In a roaring bull market, knowledge is superfluous and experience is a handicap.” 
– Benjamin Graham

The third quarter has mercifully come to an end. Ye shall not be missed. This was the worst quarter for Wall Street in four years. All told, the S&P 500 lost 6.94% in Q3.

But here’s an interesting fact: The market’s pain was overwhelmingly concentrated within a four-session span that ranged from August 20 to August 25. In fact, if we isolate just two of those days, Friday, August 21 and Monday, August 24, the S&P 500 lost 7.00%. In other words, outside those two successive days, the market was up by a teeny bit last quarter.

big10022015

Naturally, you could say this is cherry-picking the data, and to some degree, that’s correct. But it highlights an important point I often

stress to investors—selloffs are quick and sharp, while recoveries are slow and steady. In fact, sell-offs are often mostly over at just about the time people are wondering if we’re in one.

 

That was certainly true this week. Billionaire Carl Icahn made headlines by saying that the stock market is in “dangerous territory.” (Icahn outlined his thoughts in a video entitled “Danger Ahead.”) Of course, his warning comes more than a month after the market’s August turbulence, and more than four months after the market’s May peak. Investing is the one area of human activity where people are unnerved by lower prices.

In this week’s CWS Market Review, we’ll take a closer look at our Buy List’s performance so far. The bad news is that we’re down for the year. The good news is that we’re not as down as much as everyone. Of course, being a bit less bad than everybody else will get you far on Wall Street. We also had a blow-out sales report from Ford Motor (F). The automaker just registered its best September in eleven years. I’ll also explain why the market’s recent “retest” was so unbalanced. But first, let’s see how well our Buy List has fared this year.

Three Quarters Down, and We’re Beating the Market

On Wednesday, September 30, the S&P 500 closed at 1,920.03. That gave the index a YTD loss of 6.74%. If you add in dividends, then the index was down 5.29%.

The 21 stocks on our Buy List finished the third quarter with a YTD loss of 2.22%. Once you include dividends, the loss was 1.37%, so we’re running about 4% ahead of the overall market. For tracking purposes, I assume the Buy List is a $1 million portfolio at the start of the year. The portfolio is divided equally among the 20 stocks, so we start with $50,000 in each position. The Buy List now includes 21 stocks as a result of eBay’s spinning off PayPal.

As always, the rules of the Buy List forbid me from making any changes during the year. Each December, I’ll announce our portfolio changes. We’ll have five new buys and five sells (this December, there will be six sells due to PayPal). After that, the Buy List is locked and sealed for the next 12 months.

We had a nice run of beating the S&P 500 for seven years in a row until we lost to the market last year. (It was close: 13.69% to 11.80%.) Fortunately, we’re back to our market-beating ways in 2015.

This is the tenth year for the Buy List. If you were to group all 9.75 years together, then our Buy List has gained 147.84% to the S&P 500’s 89.10%. Basically, we turned every $2 into $5. Bear in mind, we did this with very little trading.

(Side note: When I give the performance of the long-term Buy List, I calculate it by assuming annual rebalancing. I realize that very few investors do this, nor is it necessary. But I believe it’s the fairest way to state our long-term results.)

At the end of three quarters, our best-performing stock is Fiserv (FISV), with a 22% gain. This quiet stock just goes up and up. In second place is one of our new additions this year, Hormel Foods (HRL), with a 21.5% gain. The Spam company has held up quite well recently. That’s what I like about consumer staples. When times get rough, people cut back on luxuries, but not on things like Dinty Moore (yep, a Hormel brand).

The also-rans of this year’s Buy List are dominated by four underachievers: Oracle (ORCL), Qualcomm (QCOM), Bed Bath & Beyond (BBBY) and Moog (MOG-A). Oracle was down 19.7% at the end of Q3, while the other three were all down by more than 25%.

This highlights another important fact of investing. Your worst positions will often be down more than your best positions are up. Not always, but it’s true often enough. Remarkably, 15 of our 21 stocks have outperformed the market this year. The problem is that the duds really weigh down our performance. That’s why diversification is so important. Investors should always make sure their portfolios are broadly diversified. Now let’s turn to one of our more frustrating stocks, but one I still like.

Ford’s Best September in Eleven Years

Beleaguered Ford Motors (F) finally got some good news this week. Ford reported sales growth of 23% last month. That’s a very good number. Wall Street had been expecting 19%. With interest rates low and gas prices down, buying and driving a new car isn’t much of an obstacle for many Americans.

Sales of Ford’s F-Series pickups were up 16%, and their SUV’s did especially well. Commercial-van sales were up 86%. This was their best month in 29 years. These numbers suggest that Ford closed Q3 on a strong note. The automaker had a very good report for Q2, beating the Street by 10 cents per share, but that hasn’t helped the stock.

big10022015a

Shares of Ford have been rocked back and forth ever since the market broke down in late August. The stock briefly dripped below $13 per share before rallying to nearly $15 two weeks ago. It dropped back again to $13 per share earlier this week. There’s also the looming threat of a strike at an F-150 plant in Kansas City. Don’t worry. I’m inclined to believe some agreement will be reached before Sunday’s deadline.

I still like Ford a lot, and I’m surprised the shares are so low. The company has stood by its earnings forecast all year, and the dividend is sound. Ford remains an attractive buy up to $15 per share.

Wait till the VIX Hits 20

A few weeks ago, I told you that the coast will be clear once the Volatility Index (^VIX) closes below 20. Since then, the VIX has come close a few times, but hasn’t yet closed below that target. We can use that as a rough indicator for the market’s state of mind.

In last week’s CWS Market Review, I wrote, “I wouldn’t be surprised if the S&P 500 tries to ‘retest’ its low of 1,870.” That’s exactly what happened. This past Tuesday, the S&P 500 dropped down to an intra-day low of 1,871.9, which is less than five points above the intra-day low from August 24.

Technical analysts pay attention to when the market goes back to “test” its previous low points. The theory goes that if the test fails, then you can expect the downtrend to continue. But if the old low holds, then that bodes well for the start of a new uptrend. So far, the old low has held. (So far.)

What’s interesting about this retest is how unbalanced it is. Let me explain. When the market gets nervous, investors run for cover in more stable stocks, and that generally means large-caps. As a result, the mammoth-cap stocks have not been the ones resetting their lows. Rather, it’s been the little guys. They’ve not only been testing the lows, the lows have been falling left and right. The small-cap Russell 2000 recently fell for eight days in a row.

Bloomberg notes that 42% of the stocks in the S&P 500 have slipped below their August 25 low. In fact, if we look at three Mongo-caps, ExxonMobil (XOM), Microsoft (MSFT) and Apple (AAPL), they’ve combined for nearly 20% of the index’s gain since the recent low. The S&P 500 Equal Weighted Index has already made a new low. In other words, for most stocks, the market’s correction is still going strong.

Is this a sign of more bad times to come? Will the big-caps finally give in? I can’t say for sure, but the good news is that we don’t need to worry about timing the market to do well. Instead, our strategy is to focus on strong companies that are going for good prices.

Some of the stocks I like right now on our Buy List are AFLAC (AFL), The selling at Moog (MOG-A) has gotten to be a bit much. The stock is especially attractive below $55 per share. Again, I like Ford Motor (F). If you can get it below $14, you got a good deal. Now let’s look at some other Buy List stocks.

Buy List Updates

If you recall, Ball Corp. (BLL), one of our Buy List stocks, wants to take over Rexam. The problem is that the anti-trust authorities in Europe aren’t too wild about the idea. I can’t say that’s entirely surprising, since the companies are the #1 and #2 can-makers.

This week, the EU formally raised its objections to the deal. That’s actually good news, because now Ball has something concrete to work with. They can alter the deal to meet the approval of regulators. Most likely, this means Ball will have to sell off some assets. Ball and Rexam have a deadline of December 9 to respond to the EU’s objections. Ball sounds very confident that the merger will eventually be approved. This will be a good deal for Ball.

I also want to lower my Buy Below prices for two of our stocks. The selling pressure has been rough this last month, and I want our Buy Below prices to reflect that. I’m lowering PayPal’s (PYPL) Buy Below to $34 per share. I’m also lowering Wabtec’s (WAB) to $95 per share. Last week, I said I especially like Wabtec when it’s below $90 per share.

Finally, let me note that Bank of America Merrill Lynch just upgraded Microsoft (MSFT) from underperform to neutral. They raised its target price from $39 to $47 per share. This stock is going for a good price.

That’s all for now. The big September jobs report is due out later today. Earnings season kicks off next week, when Alcoa reports Q3 earnings on Thursday. None of Buy List stocks report next week, but Wells Fargo (WFC) will be our first stock to report the following Wednesday, October 14. Seventeen of our stocks will report over the following three weeks. Also next week, the Fed will release the minutes of their last meeting. This was the controversial “no go” meeting. It will be interesting to hear what was discussed. Be sure to keep checking the blog for daily updates. I’ll have more market analysis for you in the next issue of CWS Market Review!

– Eddy

 
unnamedNamed by CNN/Money as the best buy-and-hold blogger, Eddy Elfenbein is the editor of Crossing Wall Street. His free Buy List has beaten the S&P 500 seven times in the last eight years. This email was sent by Eddy Elfenbein through Crossing Wall Street.

Getting an Edge with Options

get an edge with optionsLast Saturday Michael introduced a special live webinar on how individual investors can use options to increase the yield on their portfolios, plus hedge against market volatilty. In response to overwhelming demand we are making the fully recorded version available to our audience AT NO COST.

Options expert Patrick Ceresna from Learn to Trade Global covers the basics, provided specific examples of how to execute these trades yourself and shows how they help their clients acheive their investing goals. We can highly recommend this FREE tutorial to help you get started using this important investing tool.

CLICK HERE to watch the complete session.

~ Ed.